Vorinostat FDA Link

A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.

Also Known As:

18F-SAHA; 18F-Suberoylanilide Hydroxamic Acid; M344; MK-0683; MK0683; N-Hydroxy-N'-phenyloctanediamide; N1-Hydroxy-N8-phenyloctanediamide; NHNPODA; Suberanilohydroxamic Acid; Suberoyl Anilide Hydroxamic Acid; Suberoylanilide Hydroxamic Acid; Zolinza; 18F Suberoylanilide Hydroxamic Acid; MK 0683; N Hydroxy N' phenyloctanediamide; N1 Hydroxy N8 phenyloctanediamide

Organic Chemicals: 140
- Amines: 4925
  - Aniline Compounds: 47
    - Anilides: 23
      - Vorinostat: 1548
  - Hydroxylamines: 16
    - Hydroxamic Acids: 245
      - Vorinostat: 1548
- Amides: 2487
  - Anilides: 23
    - Vorinostat: 1548
- Carboxylic Acids: 986
  - Hydroxy Acids: 97
    - Hydroxamic Acids: 245
      - Vorinostat: 1548

Anne Kogge Selected Research

Anne Kogge Research Topics

Disease

Drug/Important Bio-Agent (IBA)